Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 26, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001612571-26-000004
Filed / recorded
Feb 26, 2026, 11:21 PM UTC
Added to OQRO
Oct 2, 2026, 12:26 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ABBOTT LABORATORIES
Issuer CIK
1800
Ticker
ABT
Reporting person
Robert B Ford
Relationship
Director, Officer
Officer title
CHAIRMAN AND CEO
Security
Common shares without par value
Table
Non-derivative (Table I)
Transaction date
Feb 24, 2026
Transaction code
A
Shares / units
83,464
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
336,769
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Gilbert Ray Cisneros, Jr. sold